MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02500nam a22003617a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
201229s20162016 xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
Ovid MEDLINE(R) |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
|---|
| PMID |
26981215 |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Dyslipidemia management in primary prevention of cardiovascular disease: Current guidelines and strategies. [Review] |
| 251 ## - Source |
|---|
| Source |
World Journal of Cardiology. 8(2):201-10, 2016 Feb 26. |
| 252 ## - Abbreviated Source |
|---|
| Abbreviated source |
World J Cardiol. 8(2):201-10, 2016 Feb 26. |
| 253 ## - Journal Name |
|---|
| Journal name |
World journal of cardiology |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Year |
2016 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Manufacturer |
FY2016 |
| 265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
|---|
| Publication status |
ppublish |
| 266 ## - Date added to catalog |
|---|
| Date added to catalog |
2020-12-29 |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
Cardiovascular disease is the leading cause of death in the United States. In 2010, the Centers for Disease Control and Prevention estimated that |
| -- |
44 billion was spent on cardiovascular diseases alone, about |
| -- |
of every |
| Linkage |
spent on health care. As life expectancy continues to increase, this annual cost will also increase, making cost-effective primary prevention of cardiovascular disease highly desirable. Because of its role in development of atherosclerosis and clinical events, dyslipidemia management is a high priority in cardiovascular prevention. Multiple major dyslipidemia guidelines have been published around the world recently, four of them by independent organizations in the United States alone. They share the goal of providing clinical guidance on optimal dyslipidemia management, but guidelines differ in their emphasis on pharmacotherapy, stratification of groups, emphasis on lifestyle modification, and use of a fixed target or percentage reduction in low density lipoprotein cholesterol. This review summarizes eight major guidelines for dyslipidemia management and considers the basis for their recommendations. Our primary aim is to enhance understanding of dyslipidemia management guidelines in patient care for primary prevention of future cardiovascular risk. |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
English |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
IN PROCESS -- NOT YET INDEXED |
| 651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
|---|
| Institution |
MedStar Union Memorial Hospital |
| 657 ## - INDEX TERM--FUNCTION |
|---|
| Medline publication type |
Journal Article |
| 657 ## - INDEX TERM--FUNCTION |
|---|
| Medline publication type |
Review |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Adesiyun, Tolulope |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Blumenthal, Roger S |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Hendrani, Aditya D |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Jones, Steven R |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Martin, Seth S |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Quispe, Renato |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Stone, Neil J |
| 790 ## - Authors |
|---|
| All authors |
Adesiyun T, Blumenthal RS, Hendrani AD, Jones SR, Martin SS, Quispe R, Stone NJ |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| DOI |
<a href="https://dx.doi.org/10.4330/wjc.v8.i2.201">https://dx.doi.org/10.4330/wjc.v8.i2.201</a> |
| Public note |
https://dx.doi.org/10.4330/wjc.v8.i2.201 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Journal Article |
| Item type description |
Article |
